- Home
- / Proteon Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Proteon Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$33.4
2020-01-09
Market Capitalization
$18.5 M
2020-01-09
Revenue
$2.9 M
FY, 2014
CreditSafe Score
?
Score changed on Jul 18, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.9M | |||||||
| General and administrative expense | 4.1M | 8.5M | 9.8M | 8.7M | 9.5M | 8.8M | 22.5M | 26.4M |
| Operating expense total | 10.5M | 20.9M | 28.7M | 30.4M | 21.4M | 15.3M | ||
| EBIT | (7.6M) | (20.9M) | (28.7M) | (30.4M) | (21.4M) | (15.3M) | (34.4M) | (47.5M) |
| EBIT margin, % | -257.1% | |||||||
| Investment income | 24.0K | 144.0K | 193.0K | 259.0K | 436.0K | 262.0K | 237.0K | |
| Interest income | 5.1M | 237.0K | ||||||
| Pre tax profit | (28.5M) | (30.0M) | (20.7M) | (15.0M) | ||||
| Income tax expense | (110.0K) | (4.6M) | ||||||
| Net Income | (3.3M) | (21.4M) | (28.5M) | (30.0M) | (20.7M) | (15.0M) | (34.0M) | (47.3M) |